| Serial Number | 97748253 |
| Word Mark | NIPPON CHEMIPHAR |
| Filing Date | Tuesday, January 10, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, June 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 16, 2024 |
| Goods and Services | Pharmaceutical preparations for Cardiovascular Disorders, Genitourinary Disorders, Gynecological diseases, Cancer and cancer supportive care, Eye Disorders, Neurologic Disorders, Psychiatric Disorders, Endocrine and Metabolic Disorders, Allergic Disorders, Gastrointestinal Disorders, Immune Diseases and Autoimmune Diseases, Respiratory Diseases, Musculoskeletal and Connective Tissue Disorders, Infectious Diseases, Dermatologic Disorders, Hematological Disorder, Inflammatory Diseases, Ear, Nose, Dental and Throat Disorders, Hepatic and Biliary Disorders, Kidney Diseases, Medicines for improving sleep, Medicines for controlling sickness from drinking, Medicines for controlling hangovers; Obstetric medicines being medical preparations for the treatment of endometriosis or adenomyosis; local, topical, general, inhalant anesthetic; Sedatives; Analgesic drugs; Alkalinizing agents being preparations for the lowering pH levels in patients; Anti-aging agents being pharmaceutical preparations for reducing the effects of aging in patients; reagent paper for medical purposes; pharmaceutical preparations for reducing pain, reducing inflammation; pharmaceutical preparations and substances with antipyretic properties anti-inflammatories and analgesic properties for the treatment of nociceptive pains, the treatment of neuropathic pains, the treatment of visceral pains, the treatment of rheumatoid arthritis, the treatment of low back pain, and the treatment of after surgery, trauma, and tooth extraction; pharmaceutical preparations for the treatment of gout and hyperuricemia; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations and substances for the treatment of cancer; Hygiene agent, namely, medical cleanser for skin and wounds; Eye patches and skin patches for medical purposes, namely, pharmaceutical preparations for reducing pain, reducing inflammation; medicated ointments for treating dermatological conditions; Infusion drug for medical purposes, namely, pharmaceutical preparations for reducing pain, reducing inflammation that need to be administered gradually intravenously; Diagnostic agents and reagents for medical use; diagnostic reagents for medical purposes; Medical diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; In vitro diagnostic reagent for medical use; In vitro diagnostic reagents kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in determining allergies; medical oiled paper; Drug delivery agents in the form of wafers for wrapping powdered pharmaceuticals for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages spray; Breast-nursing pads; cotton swabs for medical use; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; Vitamin fortified beverages for babies for medical purposes; food for babies; dietary-supplements-for-animals other than drugs; Semen for artificial insemination; ferments for pharmaceutical purposes; Food supplements, namely, antioxidant pills; dietary supplements for anti-aging immune system for humans; appetite suppressant pills; dietary fiber to aid digestion; pharmaceutical preparations for treating dry skin; Pharmaceutical preparations being medical application cream pharmaceuticals for treating skin conditions; pharmaceutical preparations for skin care; Nasal sprays for medical purposes |
| Translation of Words in Mark | The English translation of NIPPON in the mark is Japan. |
| Goods and Services | Diagnostic reagents for medical research; Diagnostic reagent kits consisting of chemical reagents, cell culture reagents, biochemical reagents for medical research |
| NOT AVAILABLE | "NIPPON" |
| Goods and Services | Medical apparatus and instruments, namely, medical devices for use in diagnosing allergies; Medical diagnostic apparatus and instruments for diagnostic for immunotherapy medical purposes; Medical diagnostic apparatus and instruments, namely, medical devices for use in diagnosing allergies; apparatus for use in medical purpose for identifying allergens causing allergy, namely, medical devices for use in diagnosing allergies; medical diagnostic apparatus for testing and quantifying the amount of allergen-specific antibody; Genetic testing apparatus for medical purposes; medical measuring apparatus, namely, medical apparatus for measuring skin hydration; Medical diagnostic apparatus for measuring, testing and analyzing specimens reacted with diagnostic reagents; medical diagnostic apparatus, namely, immunoassay analyzer being medical diagnostic apparatus for testing for viruses; mobile medical apparatus for enzyme-linked immunosorbent assay, namely, medical diagnostic apparatus for testing for blood protein, DNA for allergy screening; medical diagnostic apparatus for testing and measuring specific immunoglobulin E (IgE) antibodies; Sanitary masks for personal use; dental materials being dental implants |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 31, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 31, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 31, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nippon Chemiphar Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 101-0032 JP |
| Event Date | Event Description |
| Friday, January 13, 2023 | NEW APPLICATION ENTERED |
| Tuesday, January 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 3, 2023 | ASSIGNED TO EXAMINER |
| Thursday, October 5, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, October 5, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, October 5, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 23, 2024 | FINAL REFUSAL WRITTEN |
| Friday, February 23, 2024 | FINAL REFUSAL E-MAILED |
| Friday, February 23, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, May 22, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, May 22, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 22, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 22, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 23, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 23, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 23, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 23, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 30, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, June 26, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |